These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18860340)

  • 1. The demonstration and characterization of the anti-d agglutinin and antigen predicted by Fisher and Race.
    HABERMAN S; HILL JM
    Blood; 1948 Jun; 3(6):682-8. PubMed ID: 18860340
    [No Abstract]   [Full Text] [Related]  

  • 2. [The identification of dry blood spots. I. Research of the C, D and E factors of the Rhesus system. II. Demonstration of the irregular agglutinins anti-M, anti-D, and anti-C].
    RUFFIE J; DUCOS J
    Ann Med Leg Criminol Police Sci Toxicol; 1952; 32(5):351-61. PubMed ID: 13040842
    [No Abstract]   [Full Text] [Related]  

  • 3. Two examples of sera containing the anti-d agglutinin predicted by Fisher and Race.
    HILL JM; HABERMAN S
    Nature; 1948 May; 161(4096):688. PubMed ID: 18938458
    [No Abstract]   [Full Text] [Related]  

  • 4. [Distribution of Rh groups in Denmark; typing of 7020 persons with anti-C and anti-D].
    LYNDRUP S
    Ugeskr Laeger; 1952 Nov; 114(46):1631-6. PubMed ID: 13029271
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemolytic disease of the newborn due to both anti-Rh (D) and anti-Kell (K) antibodies.
    FRUMIN AM; KOHN A; WALDMAN S; GRAUB M
    Am J Obstet Gynecol; 1955 Sep; 70(3):663-5. PubMed ID: 13238515
    [No Abstract]   [Full Text] [Related]  

  • 6. A serologic and genetic analysis of an r'r' (dCe/dCe) patient producing anti-D and antic.
    LEVINE P; COOPER MB; KOCH EA
    Blood; 1954 Aug; 9(8):817-23. PubMed ID: 13181945
    [No Abstract]   [Full Text] [Related]  

  • 7. [FREQUENCY OF ANTI-GM AND ANTI-D SERUMS ESSENTIAL TO THE DETERMINATION OF GM BLOOD GROUPS].
    AUDRAN R
    C R Hebd Seances Acad Sci; 1964 Nov; 259():4183-5. PubMed ID: 14260663
    [No Abstract]   [Full Text] [Related]  

  • 8. [EXPERIMENTAL CONTRIBUTIONS ON THE DEMONSTRATION OF INCOMPLETE RH-ANTIBODIES. II. STATISTICAL EVALUATION OF VARIOUS SUPPLEMENTS IN THE DEMONSTRATION OF RH-ANTIBODY].
    SCHNEEWEISS B; LANGE A
    Z Kinderheilkd; 1964 Sep; 90():333-40. PubMed ID: 14316615
    [No Abstract]   [Full Text] [Related]  

  • 9. THE EFFECT OF FICIN ON THE REACTION BETWEEN ANTI-D AND RED CELLS.
    HUGHES-JONES NC; GARDNER B; TELFORD R
    Vox Sang; 1964; 9():175-82. PubMed ID: 14147434
    [No Abstract]   [Full Text] [Related]  

  • 10. [Findings about the antigen structure of the Rh factor and about the nature of Rh antibodies; recent experience with RH agglutinin after birth].
    GYONGYOSSY A
    Praxis; 1949 Dec; 38(51):1113-6. PubMed ID: 15408554
    [No Abstract]   [Full Text] [Related]  

  • 11. INHIBITION OF AN ANTI-D BY A NORMAL SERUM FACTOR.
    FREIESLEBEN E; JENSEN KG
    Vox Sang; 1964; 9():65-9. PubMed ID: 14115409
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical significance of Rh antibodies (Rh agglutinins and blocking antibodies) in the sera of Rh-negative mothers; a study of 179 cases.
    HOWARD J; LUCIA SP
    Am J Obstet Gynecol; 1947 Apr; 53(4):569-95. PubMed ID: 20291228
    [No Abstract]   [Full Text] [Related]  

  • 13. Cold agglutinin activity is common among human monoclonal IgM Rh system antibodies using the V4-34 heavy chain variable gene segment.
    Thorpe SJ; Boult CE; Stevenson FK; Scott ML; Sutherland J; Spellerberg MB; Natvig JB; Thompson KM
    Transfusion; 1997; 37(11-12):1111-6. PubMed ID: 9426632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THE EFFECT OF PH AND IONIC STRENGTH ON THE REACTION BETWEEN ANTI-D AND ERYTHROCYTES.
    HUGHES-JONES NC; GARDNER B; TELFORD R
    Immunology; 1964 Jan; 7(1):72-81. PubMed ID: 14113078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on Rh antibodies; the demonstration of a third type of Rh antibody with blocking properties.
    MOHN JF; WITEBSKY E
    J Lab Clin Med; 1948 Nov; 33(11):1361-8. PubMed ID: 18890026
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of antigen strength, agglutinin and incomplete antibody on agglutination by anti-D sera.
    RENTON PH; HANCOCK JA
    Br J Haematol; 1958 Jan; 4(1):89-96. PubMed ID: 13499837
    [No Abstract]   [Full Text] [Related]  

  • 17. AUTO-IMMUNE ANTI-D SPECIFICITY IN INFANCY.
    GROSS S; NEWMAN AJ
    Am J Dis Child; 1964 Aug; 108():181-3. PubMed ID: 14159938
    [No Abstract]   [Full Text] [Related]  

  • 18. Human monoclonal antibodies encoded by the V4-34 gene segment show cold agglutinin activity and variable multireactivity which correlates with the predicted charge of the heavy-chain variable region.
    Thorpe SJ; Turner CE; Stevenson FK; Spellerberg MB; Thorpe R; Natvig JB; Thompson KM
    Immunology; 1998 Jan; 93(1):129-36. PubMed ID: 9536129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of race and phenotype on the erythrocyte D antigen studied by I-131-labeled anti-D.
    BARNES AE; FARR R
    Blood; 1963 Apr; 21():429-46. PubMed ID: 13969352
    [No Abstract]   [Full Text] [Related]  

  • 20. An Rh-o (D) positive patient whose serum contains anti-Rh-o (D) antibodies. Family studies.
    FRANCIS BJ; HATCHER DE; MARCUSE PM
    Vox Sang; 1960 Jul; 5():324-9. PubMed ID: 13701231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.